IMC Chicago LLC Raises Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

IMC Chicago LLC lifted its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 17.5% during the first quarter, Holdings Channel.com reports. The fund owned 12,204 shares of the company’s stock after acquiring an additional 1,821 shares during the period. IMC Chicago LLC’s holdings in VanEck Pharmaceutical ETF were worth $1,112,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. SBI Securities Co. Ltd. purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $29,000. Park Square Financial Group LLC purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $43,000. Tidemark LLC boosted its position in VanEck Pharmaceutical ETF by 123.6% in the fourth quarter. Tidemark LLC now owns 1,183 shares of the company’s stock valued at $102,000 after buying an additional 654 shares during the last quarter. OLD Mission Capital LLC purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $224,000. Finally, Focus Partners Wealth purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $243,000.

VanEck Pharmaceutical ETF Trading Down 0.1%

Shares of NASDAQ:PPH opened at $90.42 on Thursday. VanEck Pharmaceutical ETF has a 12-month low of $77.67 and a 12-month high of $99.51. The company has a market capitalization of $564.22 million, a PE ratio of 24.60 and a beta of 0.55. The business has a 50 day moving average of $85.92 and a two-hundred day moving average of $88.19.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 4th. Shareholders of record on Tuesday, April 1st were issued a $0.5245 dividend. The ex-dividend date was Tuesday, April 1st. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $2.10 dividend on an annualized basis and a yield of 2.32%.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.